^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    PF-07224826

    i
    Other names: PF-07224826, PF 07224826, PF07224826
    Associations
    News
    Trials
    Company:
    Pfizer
    Drug class:
    CDK2/4/6 inhibitor
    Related drugs:
    Associations
    News
    Trials